BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24651453)

  • 1. HD chromoendoscopy coupled with DNA mass spectrometry profiling identifies somatic mutations in microdissected human proximal aberrant crypt foci.
    Drew DA; Devers TJ; O'Brien MJ; Horelik NA; Levine J; Rosenberg DW
    Mol Cancer Res; 2014 Jun; 12(6):823-9. PubMed ID: 24651453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proximal Aberrant Crypt Foci Associate with Synchronous Neoplasia and Are Primed for Neoplastic Progression.
    Drew DA; Mo A; Grady JJ; Stevens RG; Levine JB; Brenner BM; Anderson JC; Forouhar F; O'Brien MJ; Devers TJ; Rosenberg DW
    Mol Cancer Res; 2018 Mar; 16(3):486-495. PubMed ID: 29222172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of expression of DNA mismatch repair proteins in aberrant crypt foci identified in vivo by magnifying colonoscopy in subjects with hereditary nonpolyposic and sporadic colon rectal cancer.
    Ramírez-Ramírez MA; Sobrino-Cossío S; de la Mora-Levy JG; Hernández-Guerrero A; Macedo-Reyes Vde J; Maldonado-Martínez HA; Alonso-Larraga JO; Ramírez-Solis ME
    J Gastrointest Cancer; 2012 Jun; 43(2):209-14. PubMed ID: 21744313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoproteomic analysis of extracellular receptor kinase-1/2 post-translational activation in microdissected human hyperplastic colon lesions.
    Drew DA; Devers T; Horelik N; Yang S; O'Brien M; Wu R; Rosenberg DW
    Proteomics; 2013 May; 13(9):1428-36. PubMed ID: 23467982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation study of tumor suppressor genes in human aberrant crypt foci, colorectal carcinomas, and normal colon.
    Sarangi J; Das P; Ahmad A; Sulaiman M; Ghosh S; Gupta B; Panwar R; Pal S; Yadav R; Ahuja V; Sen S; Upadhyay AD; Dash NR; Sharma A; Gupta SD
    J Cancer Res Ther; 2024 Jan; 20(1):268-274. PubMed ID: 38554332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention.
    Clapper ML; Chang WL; Cooper HS
    Cancer Prev Res (Phila); 2020 Mar; 13(3):229-240. PubMed ID: 32132117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation of the PTCH1 gene promoter region in aberrant crypt foci.
    Peng L; Hu J; Li S; Wang Z; Xia B; Jiang B; Li B; Zhang Y; Wang J; Wang X
    Int J Cancer; 2013 Jan; 132(2):E18-25. PubMed ID: 22945423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of High-Risk Aberrant Crypt Foci and Mucin-Depleted Foci in the Human Colon With Study of Colon Cancer Stem Cell Markers.
    Gupta B; Das P; Ghosh S; Manhas J; Sen S; Pal S; Sahni P; Upadhyay AD; Panda SK; Gupta SD
    Clin Colorectal Cancer; 2017 Sep; 16(3):204-213. PubMed ID: 27789195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal Aberrant Crypt Foci in Humans Are Not Surrogate Markers for Colorectal Cancer Risk.
    Quintanilla I; López-Cerón M; Jimeno M; Cuatrecasas M; Zabalza M; Moreira L; Alonso V; Rodríguez de Miguel C; Muñoz J; Castellvi-Bel S; Llach J; Castells A; Balaguer F; Camps J; Pellisé M
    Clin Transl Gastroenterol; 2019 Jun; 10(6):e00047. PubMed ID: 31136360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy.
    Anderson JC; Swede H; Rustagi T; Protiva P; Pleau D; Brenner BM; Rajan TV; Heinen CD; Levine JB; Rosenberg DW
    Cancer Causes Control; 2012 Feb; 23(2):355-61. PubMed ID: 22187142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of rectal aberrant crypt foci for intraepithelial neoplasia in ulcerative colitis - a cross-sectional study.
    Freire P; Figueiredo P; Cardoso R; Manuel Donato M; Ferreira M; Mendes S; Silva MR; Cipriano MA; Ferreira AM; Vasconcelos H; Portela F; Sofia C
    Scand J Gastroenterol; 2014 Oct; 49(10):1219-29. PubMed ID: 25157637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Number of aberrant crypt foci in the rectum is a useful surrogate marker of colorectal adenoma recurrence.
    Uchiyama T; Takahashi H; Endo H; Kato S; Sakai E; Hosono K; Yoneda M; Inamori M; Hippo Y; Nakagama H; Nakajima A
    Dig Endosc; 2012 Sep; 24(5):353-7. PubMed ID: 22925289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG island methylation in aberrant crypt foci of the colorectum.
    Chan AO; Broaddus RR; Houlihan PS; Issa JP; Hamilton SR; Rashid A
    Am J Pathol; 2002 May; 160(5):1823-30. PubMed ID: 12000733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectal aberrant crypt foci (ACF) as a predictor of benign and malignant neoplastic lesions in the large intestine.
    Kowalczyk M; Orłowski M; Klepacki Ł; Zinkiewicz K; Kurpiewski W; Kaczerska D; Pesta W; Zieliński E; Siermontowski P
    BMC Cancer; 2020 Feb; 20(1):133. PubMed ID: 32075595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia.
    Sinicrope FA; Viggiano TR; Buttar NS; Song LMWK; Schroeder KW; Kraichely RE; Larson MV; Sedlack RE; Kisiel JB; Gostout CJ; Kalaiger AM; Patai ÁV; Della'Zanna G; Umar A; Limburg PJ; Meyers JP; Foster NR; Yang CS; Sontag S
    Cancer Prev Res (Phila); 2021 May; 14(5):573-580. PubMed ID: 33648940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
    Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
    Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology and diagnosis of aberrant crypt foci.
    Lopez-Ceron M; Pellise M
    Colorectal Dis; 2012 Apr; 14(4):e157-64. PubMed ID: 22182185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial.
    Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
    BMC Cancer; 2020 Aug; 20(1):770. PubMed ID: 32807113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite instability in aberrant crypt foci from human colons.
    Heinen CD; Shivapurkar N; Tang Z; Groden J; Alabaster O
    Cancer Res; 1996 Dec; 56(23):5339-41. PubMed ID: 8968080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prebiotics prevent the appearance of aberrant crypt foci (ACF) in the colon of BALB/c mice for increasing the gene expression of p16 protein.
    Gomides AF; de Paula SO; Gonçalves RV; de Oliveira LL; Ferreira CL; Comastri DS; Peluzio Mdo C
    Nutr Hosp; 2014 Oct; 30(4):883-90. PubMed ID: 25335677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.